PharmaCyte Biotech Inc (NAS:PMCB)
$ 2.09 -0.0254 (-1.2%) Market Cap: 17.67 Mil Enterprise Value: -25.81 Mil PE Ratio: 0 PB Ratio: 0.57 GF Score: 34/100

PharmaCyte Biotech Inc Extraordinary Shareholders Meeting Transcript

Aug 31, 2023 / 03:00PM GMT
Release Date Price: $2.45 (+0.41%)
Joshua Silverman
PharmaCyte Biotech, Inc. - Interim CEO, Director

Good morning. Welcome to the 2023 Special Meeting of Stockholders of PharmaCyte Biotech, Inc. I'm Joshua Silverman, Interim Chairman, Interim Chief Executive Officer, and Interim President of the Company, and it's my pleasure to welcome all of you.

It's 11:00 AM Eastern, and in accordance with the notice of the meeting, I call to order the 2023 Special Meeting of Stockholders of PharmaCyte Biotech, Inc.

We have chosen to have this meeting virtually to improve our stockholders' access to this meeting. It is our intention to conduct this meeting in accordance with the agenda. The agenda is currently shown on your screen available for review in the meeting's materials section of the meeting website.

There will be an opportunity for questions that are germane to the two proposals as they are presented. Please adhere to the rules of conduct attached to your agenda in asking questions at that time.

Before proceeding to the business of the meeting, I would like to introduce some people. I would like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot